We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WAB:NYSEWestinghouse Air Brake Technologies Corporation Analysis

Data as of 2026-03-10 - not real-time

$247.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Westinghouse Air Brake Technologies (WAB) closed the day at $247, comfortably above its 50‑day SMA ($239) and 200‑day SMA ($211) but still under the 20‑day SMA ($257), indicating a bullish medium‑term trend that is yet to capture short‑term momentum. The RSI sits at 44.5, suggesting neutral pressure, while the MACD histogram is negative and the signal line is bearish, warning of possible near‑term pull‑backs. Recent earnings showed an EPS of $2.10, beating consensus estimates, and revenue grew 14.8% year‑over‑year, reinforcing the company’s growth narrative. Analysts have lifted the median price target to $290, implying a ~17% upside from the current price, yet the DCF‑derived fair value of $154 flags a substantial overvaluation gap. Dividend yield remains modest at 0.43% with a low payout ratio of 14.6%, supporting dividend sustainability despite a high debt load. Short interest has fallen by over 15% to 1.37% of float, reducing short‑cover risk. Overall, the stock blends solid earnings momentum with elevated valuation multiples and a mixed technical outlook.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD signal and decreasing volume
  • Price approaching resistance around $266
  • Recent earnings beat but limited upside in near term

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong revenue growth (14.8% YoY) and forward EPS outlook
  • Analyst price targets indicating ~17% upside
  • Low dividend payout ratio supporting cash flow flexibility

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustained growth potential in freight and transit rail segments
  • Robust operating margins and cash flow generation
  • Manageable regulatory environment and low currency exposure

Key Metrics & Analysis

Financial Health

Revenue Growth14.80%
Profit Margin10.48%
P/E Ratio36.1
ROE11.10%
ROA6.06%
Debt/Equity53.02
P/B Ratio3.8
Op. Cash Flow$1.8B
Free Cash Flow$1.2B
Industry P/E29.5

Technical Analysis

TrendBullish
RSI44.5
Support$237.79
Resistance$266.27
MA 20$257.36
MA 50$239.34
MA 200$210.74
MACDBearish
VolumeDecreasing
Fear & Greed Index78.29

Valuation

Fair Value$153.65
Target Price$289.75
Upside/Downside17.31%
GradeOvervalued
TypeBlend
Dividend Yield0.43%

Risk Assessment

Beta1.04
Volatility22.44%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.